缩写名/全名 |
ONCOL REP
ONCOLOGY REPORTS |
||||||||||||||||||||
ISSN号 | 1021-335X | ||||||||||||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||||||||||||
影响因子 | 2015:2.486, 2016:2.662, 2017:2.976, 2018:3.041, 2019:3.417, | ||||||||||||||||||||
出版国家 | GREECE | ||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||
年文章数 | 593 | ||||||||||||||||||||
出版年份 | 1994 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 平均5.5月 |
||||||||||||||||||||
录用比例 | 约54.23% | ||||||||||||||||||||
投稿链接 | http://www.spandidos-publications.com/login | ||||||||||||||||||||
投稿官网 | http://www.spandidos-publications.com/or | ||||||||||||||||||||
h-index | 84 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1021-335X%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry. Author: Wu M1, Sun Q1, Mo CH1, Pang JS1, Hou JY1, Pang LL1, Lu HP1, Dang YW1, Fang SJ1, Tang D1, Chen G1, Feng ZB1. Journal: Oncol Rep. 2019 May 3. doi: 10.3892/or.2019.7147. [Epub ahead of print] PubMed DOI |
2. | The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review). Author: Liu Y1, Sun H2, Makabel B3, Cui Q4, Li J1, Su C1, Ashby CR Jr4, Chen Z4, Zhang J1. Journal: Oncol Rep. 2019 May 3. doi: 10.3892/or.2019.7148. [Epub ahead of print] PubMed DOI |
3. | CtBP1 interacts with SOX2 to promote the growth, migration and invasion of lung adenocarcinoma. Author: Liu Y1, Bian T1, Feng J1, Qian L1, Li X1, Zhang Q1, Zhang J1, Jiang D2, Liu J3, Shi J4. Journal: Oncol Rep. 2019 May 2. doi: 10.3892/or.2019.7142. [Epub ahead of print] PubMed DOI |
4. | Improving lung cancer treatment: Hyaluronic acid‑modified and glutathione‑responsive amphiphilic TPGS‑doxorubicin prodrug‑entrapped nanoparticles. Author: Lu G1, Cao L2, Zhu C3, Xie H1, Hao K1, Xia N1, Wang B2, Zhang Y1, Liu F2. Journal: Oncol Rep. 2019 May 2. doi: 10.3892/or.2019.7139. [Epub ahead of print] PubMed DOI |
5. | 125I radiation downregulates TRPV1 expression through miR‑1246 in neuroblastoma cells. Author: Zhang D1, Xu H2, Wang Y3, Wang K4, Wang Y4, Wu B5, Zhu J4, Peng L4, Gao J4, Li Z4. Journal: Oncol Rep. 2019 Apr 22. doi: 10.3892/or.2019.7133. [Epub ahead of print] PubMed DOI |
6. | CDK6 overexpression resulted from microRNA‑320d downregulation promotes cell proliferation in diffuse large B‑cell lymphoma. Author: Su H1, Chang J1, Xu M2, Sun R1, Wang J1. Journal: Oncol Rep. 2019 May 2. doi: 10.3892/or.2019.7144. [Epub ahead of print] PubMed DOI |
7. | Gene expression profile of cancer stem‑like cells in the SW480 colon adenocarcinoma cell line. Author: Wang Y1, Zhou L1, Qing Q2, Li Y3, Li L2, Dong X1, Xiao B2. Journal: Oncol Rep. 2019 May 2. doi: 10.3892/or.2019.7146. [Epub ahead of print] PubMed DOI |
8. | Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early‑stage pancreatic ductal adenocarcinoma. Author: Yang C1, Yu T1, Liu Z1, Ye X1, Liao X1, Wang X1, Han C1, Zhu G1, Qin W1, Peng T1. Journal: Oncol Rep. 2019 Apr 24. doi: 10.3892/or.2019.7135. [Epub ahead of print] PubMed DOI |
9. | Investigation of the clinical significance and prospective molecular mechanisms of cystatin genes in patients with hepatitis B virus‑related hepatocellular carcinoma. Author: Zhou X1, Wang X1, Huang K1, Liao X1, Yang C1, Yu T1, Liu J1, Han C1, Zhu G1, Su H1, Qin W1, Han Q1, Liu Z1, Huang J1, Gong Y2, Ye X1, Peng T1. Journal: Oncol Rep. 2019 May 9. doi: 10.3892/or.2019.7154. [Epub ahead of print] PubMed DOI |
10. | Annexin A2 regulates glioma cell proliferation through the STAT3‑cyclin D1 pathway. Author: Chen L1, Lin L1, Xian N2, Zheng Z1. Journal: Oncol Rep. 2019 May 9. doi: 10.3892/or.2019.7155. [Epub ahead of print] PubMed DOI |
|
|